ABCC1 and hepatocellular carcinoma: Both miR-133a and miR-326 can reduce the expression of ABCCl in the hepatoma cell line HepG2 and enhance the sensitivity of the cells to Dox, suggesting that miR-133a and miR-326 mediate MDR through modulating ABCC1.